IASMV opportunities and news

The Israel Aerospace Medical Association (IAsMA) and SpacePharma are collaborating to advance space-based drug manufacturing. They actively foster biomedical research in microgravity by seeking out innovative concepts and connecting Israeli researchers with global orbital testing opportunities and funding pipelines.

Key Aspects of the IAsMA x SpacePharma Partnership

• Concept Competitions: IAsMA and SpacePharma periodically seek strong Israeli concepts in microgravity biotechnology. Selected concepts are submitted to major international innovation challenges such as the SPRIND Orbital Bioworks which can offer funding, parabolic flight campaigns, and orbital missions.

• Miniaturized Technology Access: SpacePharma provides fully automated, AI-controlled "lab-on-a-chip" systems. Through this collaboration, researchers and clinicians can access platforms to test how microgravity environments affect proteins, stem cells, and pharmaceutical crystallization without needing manual human intervention.

• Educational Initiatives: IAsMA regularly hosts events and Journal Clubs in tandem with these developments to educate students, medical professionals, and researchers on the impact of microgravity on human physiology and pharmaceutical development.

• The Real-World Impact: Testing and manufacturing in low Earth orbit allow researchers to grow high-quality protein crystals and fine-tune drug therapeutics that are virtually impossible to create under the gravity constraint on Earth.

• 
  

• *** To learn more about aerospace medicine or to explore how to get involved, check out the IAsMA Homepage. To explore their flight-proven miniaturized lab technology, visit SpacePharma Online.